Cargando…
Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder
Recepteur d'Origine Nantais (RON) is a distinct receptor tyrosine kinase in the c-met proto-oncogene family. We examined the mutational and expression patterns of RON in eight human uroepithelial cell lines. Biological effects of RON overexpression on cancer cells were investigated in vitro, an...
Autores principales: | Cheng, H-L, Liu, H-S, Lin, Y-J, Chen, H H-W, Hsu, P-Y, Chang, T-Y, Ho, C-L, Tzai, T-S, Chow, N-H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361770/ https://www.ncbi.nlm.nih.gov/pubmed/15870710 http://dx.doi.org/10.1038/sj.bjc.6602593 |
Ejemplares similares
-
MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome
por: Lee, H E, et al.
Publicado: (2012) -
Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
por: Miyamoto, M, et al.
Publicado: (2011) -
Midkine as a prognostic biomarker in oral squamous cell carcinoma
por: Ota, K, et al.
Publicado: (2008) -
Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma
por: Keller, J, et al.
Publicado: (2013) -
High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma
por: An, H, et al.
Publicado: (2014)